Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Combination therapy, Epidemiology, MPN, Drug development, Clinical Research, Chronic Myeloid Malignancies, Therapy sequence, Diseases, Treatment Considerations, Real-world evidence, Biological therapies, Registries, Myeloid Malignancies, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Combination therapy, Epidemiology, MPN, Drug development, Clinical Research, Chronic Myeloid Malignancies, Therapy sequence, Diseases, Treatment Considerations, Real-world evidence, Biological therapies, Registries, Myeloid Malignancies, Study Population, Human
Sunday, December 8, 2024: 4:30 PM-6:00 PM
Grand Hall D
(Manchester Grand Hyatt San Diego)
Moderators:
Firas El Chaer, MD, Univesity of Virginia
and
William Shomali, MD,
Disclosures:
El Chaer: SPD Oncology: Consultancy, Research Funding; Amgen: Consultancy, Research Funding; CTI BioPharma: Consultancy; AbbVie: Consultancy; MorphoSys: Consultancy; Association of Community Cancer Centers: Consultancy; PharmaEssentia: Consultancy, Research Funding; Bristol Myers Squib: Consultancy, Research Funding; Geron: Consultancy; Sobi: Consultancy; DAVA Oncology: Consultancy, Other: Travel grant; Celgene: Research Funding; Sanofi: Research Funding; FibroGen: Research Funding; BioSight: Research Funding; MEI Pharma: Research Funding; Novartis: Research Funding; Arog Pharmaceuticals: Research Funding.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH